Original Contribution IN VITRO ACTIVITY OF LEVOFLOXACIN, GEMIFLOXACIN, LINEZOLID, VANCOMYCIN, DALBAVANCIN AND TELAVANCIN AGAINST GRAM-POSITIVE STRAINS, ISOLATED FROM CLINICAL SAMPLES
نویسندگان
چکیده
The activity of six antibacterials / levofloxacin, gemifloxacin, linezolid, vancomycin, dalbavancin and telavancin/ against 55 gram-positive strains was tested using MIC determination. Linezolid, dalbavancin and telavancin were active against all the strains tested, with low MIC’s levels. The MIC’s range for dalbavancin was 0.012-0.125 μg/ml for all strains and 0.023-0.75 μg/ml – for telavancin respectively. Gemifloxacin could be used with success for staphylococcal / MRSA / strains treatment.
منابع مشابه
Current and novel antibiotics against resistant Gram-positive bacteria
The challenge posed by resistance among Gram-positive bacteria, epitomized by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE) and vancomycin-intermediate and -resistant S. aureus (VISA and VRSA) is being met by a new generation of antimicrobials. This review focuses on the new β-lactams with activity against MRSA (ceftobiprole and ceftaroline) and on ...
متن کاملMethicillin-resistant Staphylococcus aureus therapy: past, present, and future.
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be associated with significant morbidity and mortality. Vancomycin was the "gold standard" of treatment for serious MRSA infections; however, the emergence of less-susceptible strains, poor clinical outcomes, and increased nephrotoxicity with high-dose therapy are challenging its current role as first-line therapy. Linezolid is rec...
متن کاملGlycopeptide Antibiotics: Structure and Mechanisms of Action
Glycopeptides of the clinically important antibiotic drugs are glycosylated cyclic or polycyclic nonribosomal peptides. Glycopeptides such as vancomycin and teicoplanin are often used for the treatment of gram-positive bacteria in patients. The increased incidence of drug resistance and inadequacy of these therapeutics against gram-positive bacterial infections would be the formation and clinic...
متن کاملGlycopeptides in clinical development: pharmacological profile and clinical perspectives.
Vancomycin and teicoplanin are the two glycopeptides currently used in the clinics for the treatment of multiresistant infections by Gram-positive organisms. The development of resistance in enterococci and staphylococci has stimulated the search for new derivatives with improved activity, particularly against strains resistant to conventional derivatives. Three of these, obtained by hemi-synth...
متن کاملSkin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians. Although uncomplicated SSTIs are managed successfully on an outpatient basis, more serious infections extending to the subcutaneous tissue, fascia, or muscle require complex management. Early diagnosis, selection of appropriate a...
متن کامل